The Patent Finder

Methods and Compositions for Modulating Angiogenesis and Vasculogenesis

Sanbio, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 15/063,290, filed Mar 7, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,245,286Methods and Compositions for Modulating Angiogenesis and Vasculogenesis
In force
 · Medium confidence
Sanbio, Inc.In force
Medium confidence
US 12,171,787Methods and Compositions for Modulating Angiogenesis and Vasculogenesis
In force
 · High confidence
Sanbio, Inc.In force
High confidence
US 11,304,982Methods and Compositions for Modulating Angiogenesis and Vasculogenesis
In force
 · Medium confidence
Sanbio, Inc.In force
Medium confidence
Application 13/750,772Methods and Compositions for Modulating Angiogenesis and Vasculogenesis
Abandoned
Abandoned May 25, 2016
Sanbio, Inc.AbandonedAbandoned May 25, 2016
Application 15/063,290Methods and Compositions for Modulating Angiogenesis and Vasculogenesis
Abandoned
Abandoned Nov 13, 2017
Sanbio, Inc.AbandonedAbandoned Nov 13, 2017
Application 18/941,420Methods and Compositions for Modulating Angiogenesis and Vasculogenesis
Pending
Not granted
Sanbio, Inc.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Sanbio, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited